Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06691386 · ClinicalTrials.gov registry record · NA
Nicotine Pharmacokinetics and Subjective Effects of Oral Nicotine Products Relative to Smokeless Tobacco in Adult Users
A NA study, sponsored by Altria Client Services.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT06691386 is a NA study that has completed, run by Altria Client Services. The registered enrollment target is 64 participants.
The verdict
NCT06691386, a NA study, has completed, sponsored by Altria Client Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The purpose of this study was to obtain information on nicotine exposure following the use of five oral tobacco-derived nicotine (OTDN) products relative to subjects' own brand moist smokeless tobacco (OBMST) product in adult moist smokeless tobacco (MST) users, as well as to characterize subjective effects under controlled use conditions. Male and female adult MST users between the ages of 22 to 65 years were recruited. The total duration of participation for each subject was approximately 34 days including screening and a 6-day in-clinic study confinement period.
Interventions
- OTHER Test Product A
- OTHER Test Product B
- OTHER Test Product C
- OTHER Test Product D
- OTHER Test Product E
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2023-02-06 |
| Est. Completion | 2024-02-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06691386
The ClinicalTrials.gov registry entry for NCT06691386 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Altria Client Services, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Test Product A is the first listed.
NCT06691386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06691386 about?
NCT06691386 is a clinical study titled "Nicotine Pharmacokinetics and Subjective Effects of Oral Nicotine Products Relative to Smokeless Tobacco in Adult Users". The purpose of this study was to obtain information on nicotine exposure following the use of five oral tobacco-derived nicotine (OTDN) products relative to subjects' own brand moist smokeless tobacco (OBMST) product in adult moist smokeless tobacco (MST) users, as well as to characterize subjective...
What is the current status of trial NCT06691386?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2023-02-06. Estimated completion is 2024-02-08.
What interventions are being tested in trial NCT06691386?
The interventions under investigation include: Test Product A (OTHER), Test Product B (OTHER), Test Product C (OTHER), Test Product D (OTHER), Test Product E (OTHER).
Who is sponsoring clinical trial NCT06691386?
This trial is sponsored by Altria Client Services, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.